by Truveta Research | Jul 23, 2025 | Research, Research Insights
The rate of pediatric fluoride prescriptions per all prescriptions decreased by 54.3% from the first quarter of 2022 (5.0 per 1,000 prescriptions) to the second quarter of 2025 (2.3 per 1,000 prescriptions). Across the study period, the 10 US states with lowest...
by Truveta staff | Jul 21, 2025 | Research
In this Truveta experts spotlight, Jared Kern and Vidya Venkataraman, PhD explored trends in the use of Rituxan biosimilars between 2018 and 2024. Their analysis of Truveta Data reveals how patient access and switching behavior has evolved over time. Jared Kern is a...
by Truveta Research | Jul 16, 2025 | Research, Research Insights
The proportion of patients initiating treatment for multiple sclerosis (MS) with a high efficacy disease-modifying therapy (DMT) more than doubled from 2018 to 2025, reflecting evolving clinical guidelines. Use of oral and injectable therapies showed a gradual decline...
by Truveta Research | Jul 14, 2025 | Research, Research Insights
In 2023, the American Academy of Pediatrics (AAP) released groundbreaking new guidelines recommending early treatment for childhood and adolescent obesity—including the use of medications for weight management in adolescents and cautioning against the common practice...
by Truveta staff | Jul 9, 2025 | Research
This post kicks off our new series, Truveta experts— a spotlight on the data scientists, researchers, clinicians, and analysts working behind the scenes to drive healthcare research forward with real-world data. Our first contributor is Mantas Dmukauskas, PhD, a...
by Truveta staff | Jun 30, 2025 | Research
A new peer-reviewed study from researchers at Saint Luke’s Mid America Heart Institute, Impulse Dynamics, and the Cardiovascular Research Foundation demonstrates the power of real-world data to evaluate device therapies. By evaluating survival outcomes of cardiac...
